Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.

[1]  M. O’Kennedy,et al.  Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses , 2018, Veterinary Research.

[2]  D. Martin,et al.  African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004–2014 , 2016, Emerging infectious diseases.

[3]  D. Martin,et al.  Complete Genome Sequences of Four African Horse Sickness Virus Strains from a Commercial Tetravalent Live Attenuated Vaccine , 2015, Genome Announcements.

[4]  A. van Schalkwyk,et al.  Development of three triplex real-time reverse transcription PCR assays for the qualitative molecular typing of the nine serotypes of African horse sickness virus. , 2015, Journal of virological methods.

[5]  D. Martin,et al.  Complete Genome Sequences of the Three African Horse Sickness Virus Strains from a Commercial Trivalent Live Attenuated Vaccine , 2015, Genome Announcements.

[6]  S. Lecollinet,et al.  African horse sickness. , 2015, Revue scientifique et technique.

[7]  N. Robinson,et al.  Robinson's Current Therapy in Equine Medicine , 2014 .

[8]  J. Crafford,et al.  Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines. , 2014, Vaccine.

[9]  J. Grewar,et al.  The 2011 outbreak of African horse sickness in the African horse sickness controlled area in South Africa. , 2013, Journal of the South African Veterinary Association.

[10]  J. Crafford,et al.  Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals. , 2013, Equine veterinary journal.

[11]  I. Gardner,et al.  Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus. , 2013, Journal of virological methods.

[12]  W. van Wyngaardt,et al.  Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus. , 2012, Veterinary immunology and immunopathology.

[13]  B. Dungu,et al.  In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6. , 2010, Vaccine.

[14]  I. Gardner,et al.  Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus. , 2009, Vaccine.

[15]  T. Smit,et al.  Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals. , 2008, Vaccine.

[16]  J. Pawęska,et al.  Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera. , 2005, Journal of virological methods.

[17]  S. Samal,et al.  Analysis of mixed infection of sheep with bluetongue virus serotypes 10 and 17: evidence for genetic reassortment in the vertebrate host , 1987, Journal of virology.

[18]  J. Parker.  African horse sickness , 1976, Veterinary Record.

[19]  P. Bourdin,et al.  [Ecology of African horsesickness]. , 1974, Revue d'elevage et de medecine veterinaire des pays tropicaux.

[20]  A. Laurent,et al.  Note sur l'écologie de la peste équine africaine (PEA) , 1974 .

[21]  R. DiazMontilla,et al.  [African horse sickness]. , 1968, Bulletin - Office international des epizooties.

[22]  M. Quan,et al.  African horse sickness in naturally infected, immunised horses. , 2013, Equine veterinary journal.

[23]  J. Burroughs,et al.  Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8. , 1998, Archives of virology. Supplementum.

[24]  P. Roy,et al.  Structure of the bluetongue virus genome and its encoded proteins. , 1990, Current topics in microbiology and immunology.